Article Information
History
- June 29, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Eleonore S.V. de Sonnaville, MD1,2,*,
- Jaap Oosterlaan, PhD2,3,
- Sima A. Ghiassi2,
- Ouke van Leijden, MD2,
- Hanneke van Ewijk, PhD4,
- Hennie Knoester, MD, PhD1,
- Job B.M. van Woensel, MD, PhD1 and
- Marsh Königs, PhD2
- 1Amsterdam UMC, University of Amsterdam, Emma Children’s Hospital, Department of Pediatric Intensive Care, Amsterdam Reproduction and Development research institute, Amsterdam, The Netherlands
- 2Amsterdam UMC, University of Amsterdam, Emma Children’s Hospital, Department of Pediatrics, Follow-Me program & Emma Neuroscience Group, Amsterdam Reproduction and Development research institute, Amsterdam, The Netherlands
- 3Vrije Universiteit, Clinical Neuropsychology section, Amsterdam, The Netherlands
- 4Leiden University Medical Center, LUMC Curium, Department of Child and Adolescent Psychiatry, Leiden, The Netherlands
- ↵*Corresponding author:
Meibergdreef 9, 1105 AZ Amsterdam, Room H8-260 Telephone: +3120-5662008; Email-address: e.s.desonnaville{at}amsterdamumc.nl
Posted June 29, 2022.
Long-term Neurocognitive Outcomes after Pediatric Intensive Care Unit Admission: Exploring the Role of Drug Exposure
